Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

590 Articles

Paul Ausick | Jan 23, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last…

Jon C. Ogg | Jan 18, 2013 at 12:10 PM EST

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

The week ahead will be the official flood gate opening for earnings season. We have a very large portion of the…

Paul Ausick | Dec 31, 2012 at 4:04 PM EST

24/7 Wall St. Closing Bell — December 31, 2012: Markets Close 2012 on Upbeat Note (FB, ICE, BMY, AMRS, DUF, CG, ALJ, ALDW)

U.S. equity markets opened flat to lower this morning as the clock ticked down to the final hours in negotiations…

Jon C. Ogg | Dec 11, 2012 at 2:53 PM EST

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

ThinkstockTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) is not getting any great warm welcome out of its 2012 investor meeting webcast.…

Paul Ausick | Nov 30, 2012 at 4:05 PM EST

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

U.S. equity markets opened mixed this morning, but some initial enthusiasm wore off by mid-morning and stocks moved slightly lower…

Jon C. Ogg | Nov 30, 2012 at 8:23 AM EST

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday. Active…

Paul Ausick | Sep 25, 2012 at 12:06 PM EDT

No News is Good News — Peregrine Pharma

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data…

Jon C. Ogg | Sep 13, 2012 at 9:06 AM EDT

Vical Scores Big License Pact with Bristol-Myers Squibb

Vical Inc. (NASDAQ: VICL) is seeing its shares surging higher on news that it has signed a worldwide, nonexclusive licensing…

Jon C. Ogg | Sep 11, 2012 at 8:23 AM EDT

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Paul Ausick | Aug 24, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

The three major U.S. stock indexes opened lower this morning but picked up some buying steam in the first hour…

Jon C. Ogg | Aug 24, 2012 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St.…

Jon C. Ogg | Aug 2, 2012 at 11:47 AM EDT

Gilead Options & New High In Stock Bring Hope For Further Upside

Gilead Sciences Inc. (NASDAQ: GILD) is seeing shares surge today on news that Bristol-Myers Squibb Co. (NYSE: BMY) has run…

Trey Thoelcke | Jul 25, 2012 at 8:11 AM EDT

Drug Giants Show Mixed Earnings (BMY, LLY)

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.’s earnings expectations. But…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

1 … 29 30 31 32 33 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

24/7 Wall St. Closing Bell — December 31, 2012: Markets Close 2012 on Upbeat Note (FB, ICE, BMY, AMRS, DUF, CG, ALJ, ALDW)

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

24/7 Wall St. Closing Bell — December 31, 2012: Markets Close 2012 on Upbeat Note (FB, ICE, BMY, AMRS, DUF, CG, ALJ, ALDW)

Teva Fails To Impress At Its Investor Meeting, Restructuring Awaits

24/7 Wall St. Closing Bell — November 30, 2012: Market Wobbles to Lower Finish (COP, CAG, DUK, BMY, WPI, AVGO, OVTI, YOKU, ZUMZ, SOL, WWAV, LDK, VRSN, ZNGA, FB, GRPN)

Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)

No News is Good News — Peregrine Pharma

Vical Scores Big License Pact with Bristol-Myers Squibb

Top Analyst Upgrades and Downgrades (AU, AAPL, AN, BNS, BMY, CI, CLNE, CMCSA, OFC, DNKN, GFI, HMY, ICE, JCI, JNJ, SQM, FINL, WPI, YELP)

24/7 Wall St. Closing Bell — August 24, 2012: Markets Up on Macro News (BMY, KMI, STX, CPB, SPLS, ARUN, BEBE, CRM, SCVL, SOL, MSG, MDGN, SVU, ADSK)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Gilead Options & New High In Stock Bring Hope For Further Upside

Drug Giants Show Mixed Earnings (BMY, LLY)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)